Novel approaches in myelofibrosis
Abstract Myelofibrosis (MF) is a clonal myeloid neoplasm characterized by bone marrow fibrosis, splenomegaly, and disease‐associated symptoms, as well as increased mortality, due to thrombosis, severe bleeding, infections, or progression to acute leukemia. Currently, the management of MF patients is...
Saved in:
Main Author: | Steffen Koschmieder |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-12-01
|
Series: | HemaSphere |
Online Access: | https://doi.org/10.1002/hem3.70056 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic Lymphocytic Leukemia and Myelofibrosis
by: Fares Darawshy, et al.
Published: (2018-01-01) -
Successful Control of Acute Myelofibrosis with Lenalidomide
by: G. Vassilopoulos, et al.
Published: (2010-01-01) -
Dermatomyositis Associated with Myelofibrosis following Polycythemia Vera
by: Naomi Fei, et al.
Published: (2017-01-01) -
A rare case of primary myelofibrosis with novel cytogenetic abnormality – deletion 4q25
by: Debranjani Chattopadhyay, et al.
Published: (2024-12-01) -
Assessing the contribution of myelofibrosis to a leukoerythroblastic blood picture
by: Stephen E. Langabeer
Published: (2025-01-01)